We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$29.7B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
4.28%
Top 10 Hldgs %
54.74%
Holding
2,185
New
207
Increased
867
Reduced
691
Closed
168

Sector Composition

Rank Sector Weight
1 Financials 4.86%
2 Technology 4.06%
3 Healthcare 2.07%
4 Industrials 1.87%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QRVO icon
1226
Qorvo
QRVO
$7.63B
$379K ﹤0.01%
5,692
+862
+18% +$59.9K
ST icon
1227
Sensata Technologies
ST
$6.65B
$379K ﹤0.01%
7,731
+343
+5% +$16.3K
ESPR
1228
DELISTED
Esperion Therapeutics
ESPR
$377K ﹤0.01%
8,111
-19,493
-71% -$915K
QCLN icon
1229
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$633M
$377K ﹤0.01%
17,836
ILCB icon
1230
iShares Morningstar US Equity ETF
ILCB
$1.26B
$375K ﹤0.01%
9,092
VNOM icon
1231
Viper Energy
VNOM
$8.81B
$374K ﹤0.01%
12,135
-3,706
-23% -$115K
TARO
1232
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$373K ﹤0.01%
4,365
DGRW icon
1233
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.6B
$372K ﹤0.01%
8,516
+723
+9% +$31.3K
TECH icon
1234
Bio-Techne
TECH
$11.2B
$372K ﹤0.01%
7,140
TYG
1235
Tortoise Energy Infrastructure Corp
TYG
$1.14B
$372K ﹤0.01%
4,128
-7,375
-64% -$680K
TEAM icon
1236
Atlassian
TEAM
$22B
$371K ﹤0.01%
+2,839
New +$342K
B
1237
DELISTED
Barnes Group Inc.
B
$371K ﹤0.01%
6,591
-1,456
-18% -$79.3K
AYI icon
1238
Acuity Brands
AYI
$9.88B
$370K ﹤0.01%
2,682
-41
-2% -$5.64K
CPT icon
1239
Camden Property Trust
CPT
$11.3B
$370K ﹤0.01%
3,545
+61
+2% +$6.26K
FANG icon
1240
Diamondback Energy
FANG
$57.6B
$369K ﹤0.01%
3,383
+197
+6% +$20.6K
BZUN
1241
Baozun
BZUN
$144M
$368K ﹤0.01%
7,373
+495
+7% +$21.4K
TDOC icon
1242
Teladoc Health
TDOC
$1.58B
$368K ﹤0.01%
5,543
-2,229
-29% -$130K
HZNP
1243
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$368K ﹤0.01%
15,280
-1,010
-6% -$25.6K
CLR
1244
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$367K ﹤0.01%
+8,708
New +$372K
HIX
1245
Western Asset High Income Fund II
HIX
$352M
$366K ﹤0.01%
52,203
+370
+0.7% +$2.46K
PCY icon
1246
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$366K ﹤0.01%
12,620
-2,213
-15% -$62.3K
RMBS icon
1247
Rambus
RMBS
$10.4B
$366K ﹤0.01%
30,404
-300
-1% -$3.44K
CADE
1248
DELISTED
Cadence Bancorporation
CADE
$366K ﹤0.01%
17,599
-2,239
-11% -$46K
IVZ icon
1249
Invesco
IVZ
$13.3B
$365K ﹤0.01%
17,821
-3,174
-15% -$65.9K
KYN icon
1250
Kayne Anderson Energy Infrastructure Fund
KYN
$2.52B
$365K ﹤0.01%
23,866
-1,415
-6% -$22.1K

Similar funds

Creative Planning's Q2 2019 Portfolio in Review

As of Q2 2019, Creative Planning held 2,185 positions worth $29.7B, up 7.1% from $27.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.27B of net new capital in Q2 2019, opening 207 new positions and adding to 867 existing holdings. Its largest new stake was Dow Inc: 108,999 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $115M trimmed.

  • Creative Planning's largest Q2 2019 buy was Dow Inc: 108,999 shares worth $5.38M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $297M increase.
  • Creative Planning's biggest Q2 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $115M.
  • Creative Planning fully exited Intercept Pharmaceuticals, Inc. in Q2 2019, selling an estimated $3.71M.
  • Creative Planning's ten largest holdings make up 55% of its $29.7B portfolio in Q2 2019.
  • Creative Planning opened 207 new positions and closed 168 in Q2 2019.
  • Creative Planning's portfolio value rose 7.1% quarter-over-quarter to $29.7B.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.